Atrás
Rango del Día
$1.55
$2.05
Rango de 52 Semanas
$1.55
$3.26
Volumen
1,000
Promedio 50D / 200D
$1.85
/
$2.64
Cierre Anterior
$1.55
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -5.3 | 0.4 |
| P/B | 0.3 | 2.9 |
| ROE % | -6.4 | 3.7 |
| Net Margin % | -43.7 | 3.9 |
| Rev Growth 5Y % | 421.6 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$0.09
$0.08 – $0.12
|
2.8 B | 1 |
| FY2026 |
$0.04
$0.03 – $0.05
|
2.3 B | 1 |
Puntos Clave
Revenue grew 421.58% annually over 5 years — strong growth
Debt/Equity of 0.19 — conservative balance sheet
Negative free cash flow of -443.78M
Revenue growth is decelerating — 1Y growth trails 5Y average by 384.90%
Capital efficient — spends only 7.75% of revenue on capex
Crecimiento
Revenue Growth (5Y)
421.58%
Revenue (1Y)36.68%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-6.35%
ROIC-4.93%
Net Margin-43.65%
Op. Margin-52.09%
Seguridad
Debt / Equity
0.19
Current Ratio7.37
Interest Coverage-15.56
Valoración
P/E Ratio
-5.25
P/B Ratio0.34
EV/EBITDAN/A
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.68% | Revenue Growth (3Y) | 27.05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 421.58% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.01B | Net Income (TTM) | -440.63M |
| ROE | -6.35% | ROA | -4.68% |
| Gross Margin | 86.29% | Operating Margin | -52.09% |
| Net Margin | -43.65% | Free Cash Flow (TTM) | -443.78M |
| ROIC | -4.93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.19 | Current Ratio | 7.37 |
| Interest Coverage | -15.56 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | -5.25 | P/B Ratio | 0.34 |
| P/S Ratio | 2.29 | PEG Ratio | 3.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.01% |
| Market Cap | 2.32B | Enterprise Value | -2.64B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.01B | 738.54M | 625.40M | 1.04B | 1.36M |
| Net Income | -440.63M | -631.26M | -886.59M | -64.55M | -391.40M |
| EPS (Diluted) | -0.26 | -0.37 | -0.60 | -0.04 | -0.40 |
| Gross Profit | 871.01M | 610.10M | 482.01M | 977.37M | 1.36M |
| Operating Income | -525.78M | -651.15M | -770.40M | -181.10M | -558.99M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 9.41B | 9.92B | 10.32B | 7.40B | 4.54B |
| Total Liabilities | 2.66B | 2.74B | 2.68B | 1.74B | 1.38B |
| Shareholders' Equity | 6.73B | 7.15B | 7.60B | 5.60B | 3.10B |
| Total Debt | 1.27B | 1.35B | 1.25B | 1.27B | 1.17B |
| Cash & Equivalents | 6.22B | 8.22B | 8.70B | 5.93B | 3.97B |
| Current Assets | 7.82B | 8.77B | 9.30B | 6.42B | 4.09B |
| Current Liabilities | 1.06B | 2.09B | 2.08B | 329.30M | 104.45M |